NASDAQ: NUTXNutex Health Inc Stock
$111.00+16.16 (+17.04%)
Updated Oct 20, 2025
NUTX Price
$111.00
Fair Value Price
N/A
Market Cap
$617.79M
52 Week Low
$21.55
52 Week High
$184.28
P/E
8.53x
P/B
3.13x
P/S
0.42x
PEG
N/A
Dividend Yield
N/A
Revenue
$624.28M
Earnings
$67.18M
Gross Margin
48.8%
Operating Margin
19.45%
Profit Margin
10.8%
Debt to Equity
2.47
Operating Cash Flow
$71M
Beta
1.26
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
NUTX Overview
Nutex Health Inc. operates micro-hospitals, specialty hospitals, and hospital outpatient departments. It also provides a cloud-based technology platform that aggregates clinical and claims data across multiple settings, information systems, and sources to create a holistic view of patients and providers. Nutex Health was founded in 2011 and is headquartered in Houston, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NUTX's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
A
NUTX
Ranked#3 of 45
Ranked#3 of 45
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $19.77 | A | |
| $3.04 | B | |
| $20.30 | B |
Be the first to know about important NUTX news, forecast changes, insider trades & much more!
NUTX News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NUTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NUTX was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NUTX is good value based on its earnings relative to its share price (8.53x), compared to the US market average (37.98x)
P/E vs Market Valuation
NUTX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more NUTX due diligence checks available for Premium users.
Valuation
NUTX fair value
Fair Value of NUTX stock based on Discounted Cash Flow (DCF)
Price
$111.00
Fair Value
$293.62
Undervalued by
62.20%
NUTX was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
NUTX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
8.53x
Industry
76.27x
Market
37.98x
NUTX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NUTX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NUTX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.13x
Industry
4.62x
NUTX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NUTX's financial health
Profit margin
Revenue
$211.8M
Net Income
$14.6M
Profit Margin
6.9%
NUTX's Earnings (EBIT) of $121.41M... subscribe to Premium to read more.
Interest Coverage Financials
NUTX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$761.9M
Liabilities
$487.0M
Debt to equity
2.47
NUTX's short-term assets ($401.52M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NUTX's short-term assets ($401.52M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NUTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$51.0M
Investing
-$64.0k
Financing
-$6.8M
NUTX's operating cash flow ($71.07M)... subscribe to Premium to read more.
Debt Coverage Financials
NUTX vs Health Information Service Stocks
Nutex Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.